Search research articles
Contact Us
Filters
Showing results (21-30 of 78) with videos related to
Page
of 8
Sort By:
Diagnostic Microbiology and Infectious Disease
|
January 20, 2020
In vitro activity of ceftolozane/tazobactam against phenotypically defined extended-spectrum β-lactamase (ESBL)-positive isolates of Escherichia coli and Klebsiella pneumoniae isolated from hospitalized patients (SMART 2016)
James A Karlowsky, Krystyna M Kazmierczak, Katherine Young, et al.
Diagnostic Microbiology and Infectious Disease
|
June 3, 2021
Activity of imipenem/relebactam and comparators against gram-negative pathogens from patients with bloodstream infections in the United States and Canada - SMART 2018-2019
Sibylle H Lob, Meredith A Hackel, Katherine Young, et al.
JAMA
|
July 18, 1986
Mycobacterium tuberculosis bacteremia in the acquired immunodeficiency syndrome
B R Saltzman, M R Motyl, G H Friedland, et al.
Frontiers in Cellular and Infection Microbiology
|
May 28, 2026
Antimicrobial activity of ceftolozane/tazobactam, imipenem/relebactam, and comparators against Gram-negative pathogens collected in Arabian Gulf countries: SMART 2020-2024
Mark G Wise, Irina Alekseeva, Fakhar Siddiqui, et al.
Przeglad Lekarski
|
June 4, 1999
[Cognitive impairment and cardiovascular disease risk factors. Project CASCADE Kraków. V. Disorders of higher cerebral functions in elderly people (65-78 years old)]
A Szczudlik, A Słowik, W Turaj, et al.
The Journal of Antimicrobial Chemotherapy
|
August 13, 2018
Genomic characterization of IMP and VIM carbapenemase-encoding transferable plasmids of Enterobacteriaceae
Yasufumi Matsumura, Gisele Peirano, Patricia A Bradford, et al.
International Journal of Antimicrobial Agents
|
November 10, 2019
In-vitro activity of imipenem/relebactam and key β-lactam agents against Gram-negative bacilli isolated from lower respiratory tract infection samples of intensive care unit patients - SMART Surveillance United States 2015-2017
James A Karlowsky, Sibylle H Lob, Krystyna M Kazmierczak, et al.
Journal of Global Antimicrobial Resistance
|
November 8, 2019
In vitro activity of imipenem/relebactam against Enterobacteriaceae and Pseudomonas aeruginosa isolated from intraabdominal and urinary tract infection samples: SMART Surveillance United States 2015-2017
James A Karlowsky, Sibylle H Lob, Krystyna M Kazmierczak, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
May 14, 2018
Activity of Ertapenem against Enterobacteriaceae in seven global regions-SMART 2012-2016
Sibylle H Lob, Meredith A Hackel, Daryl J Hoban, et al.
Antimicrobial Agents and Chemotherapy
|
May 16, 2018
<i>In Vitro</i> Activity of Imipenem-Relebactam against Clinical Isolates of Gram-Negative Bacilli Isolated in Hospital Laboratories in the United States as Part of the SMART 2016 Program
James A Karlowsky, Sibylle H Lob, Krystyna M Kazmierczak, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 78) with videos related to
Sort By:
Page
of 8
Diagnostic Microbiology and Infectious Disease
|
January 20, 2020
In vitro activity of ceftolozane/tazobactam against phenotypically defined extended-spectrum β-lactamase (ESBL)-positive isolates of Escherichia coli and Klebsiella pneumoniae isolated from hospitalized patients (SMART 2016)
James A Karlowsky, Krystyna M Kazmierczak, Katherine Young, et al.
Diagnostic Microbiology and Infectious Disease
|
June 3, 2021
Activity of imipenem/relebactam and comparators against gram-negative pathogens from patients with bloodstream infections in the United States and Canada - SMART 2018-2019
Sibylle H Lob, Meredith A Hackel, Katherine Young, et al.
JAMA
|
July 18, 1986
Mycobacterium tuberculosis bacteremia in the acquired immunodeficiency syndrome
B R Saltzman, M R Motyl, G H Friedland, et al.
Frontiers in Cellular and Infection Microbiology
|
May 28, 2026
Antimicrobial activity of ceftolozane/tazobactam, imipenem/relebactam, and comparators against Gram-negative pathogens collected in Arabian Gulf countries: SMART 2020-2024
Mark G Wise, Irina Alekseeva, Fakhar Siddiqui, et al.
Przeglad Lekarski
|
June 4, 1999
[Cognitive impairment and cardiovascular disease risk factors. Project CASCADE Kraków. V. Disorders of higher cerebral functions in elderly people (65-78 years old)]
A Szczudlik, A Słowik, W Turaj, et al.
The Journal of Antimicrobial Chemotherapy
|
August 13, 2018
Genomic characterization of IMP and VIM carbapenemase-encoding transferable plasmids of Enterobacteriaceae
Yasufumi Matsumura, Gisele Peirano, Patricia A Bradford, et al.
International Journal of Antimicrobial Agents
|
November 10, 2019
In-vitro activity of imipenem/relebactam and key β-lactam agents against Gram-negative bacilli isolated from lower respiratory tract infection samples of intensive care unit patients - SMART Surveillance United States 2015-2017
James A Karlowsky, Sibylle H Lob, Krystyna M Kazmierczak, et al.
Journal of Global Antimicrobial Resistance
|
November 8, 2019
In vitro activity of imipenem/relebactam against Enterobacteriaceae and Pseudomonas aeruginosa isolated from intraabdominal and urinary tract infection samples: SMART Surveillance United States 2015-2017
James A Karlowsky, Sibylle H Lob, Krystyna M Kazmierczak, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
May 14, 2018
Activity of Ertapenem against Enterobacteriaceae in seven global regions-SMART 2012-2016
Sibylle H Lob, Meredith A Hackel, Daryl J Hoban, et al.
Antimicrobial Agents and Chemotherapy
|
May 16, 2018
<i>In Vitro</i> Activity of Imipenem-Relebactam against Clinical Isolates of Gram-Negative Bacilli Isolated in Hospital Laboratories in the United States as Part of the SMART 2016 Program
James A Karlowsky, Sibylle H Lob, Krystyna M Kazmierczak, et al.
Page
of 8